The growing field of targeted treatment relies heavily on recombinant mediator technology, and a precise understanding of individual profiles is essential for optimizing experimental design and therapeutic efficacy. https://bookmarkcolumn.com/story20739402/exploring-recombinant-cytokine-profiles-il-1a-il-1b-il-2-and-il-3